The SPG7 gene is associated with a condition known as spastic paraplegia 7 (SPG7), a form of hereditary spastic paraplegia. This genetic disorder is characterized by progressive weakness and stiffness of the legs, resulting from the degeneration of nerve pathways responsible for muscle movement and sensation. The SPG7 gene encodes a protein called paraplegin, which is involved in the maintenance and function of mitochondria, the energy-producing structures within cells. Mutations in the SPG7 gene disrupt the normal function of paraplegin, leading to the symptoms associated with the condition.
To diagnose this genetic condition, an SPG7 genetic test is conducted. This test specifically looks for mutations in the SPG7 gene that are known to cause spastic paraplegia 7. It is a crucial step in confirming the diagnosis, understanding the inheritance pattern, and guiding management and treatment decisions for affected individuals and their families.
In the UAE, DNA Labs UAE offers the SPG7 genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technology to ensure accurate and reliable results. By opting for this test, patients and their healthcare providers can gain valuable insights into the genetic basis of their condition, enabling a more tailored approach to treatment and management.
The REEP2 Gene SPG72 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the REEP2 gene, which is associated with the development of hereditary spastic paraplegia 72 (SPG72). SPG72 is a rare neurological disorder characterized by progressive weakness and spasticity of the legs. The test is crucial for individuals who exhibit symptoms of the disorder or have a family history of SPG72, as it helps in confirming the diagnosis, understanding the disease progression, and making informed decisions about management and therapy.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to detect any genetic abnormalities in the REEP2 gene. The procedure is known for its accuracy and reliability, providing essential insights into the genetic basis of the condition.
The cost of the REEP2 Gene SPG72 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families cannot be overstated. It not only facilitates a better understanding of the condition but also aids in the planning of treatment strategies that can improve the quality of life for those diagnosed with SPG72.
The "CPT1C Gene SPG73 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the CPT1C gene, which have been associated with spastic paraplegia 73 (SPG73), a rare neurological disorder characterized by progressive weakness and stiffness of the legs. This genetic testing is crucial for individuals displaying symptoms of SPG73, as it can provide definitive diagnosis, enabling tailored management and treatment plans. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise involved in detecting the specific gene mutations responsible for the condition. This test is a significant step forward in the field of neurogenetics, offering hope and direction for affected individuals and their families.
The WASHC5 Gene SPG8 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the WASHC5 gene, which are associated with Spastic Paraplegia 8 (SPG8). SPG8 is a rare genetic disorder characterized by progressive weakness and spasticity of the lower limbs. Early and accurate detection through this genetic test can be crucial for the management and treatment of the condition. The test involves collecting a DNA sample from the patient, which is then analyzed for specific genetic alterations in the WASHC5 gene that are indicative of SPG8. DNA Labs UAE provides this comprehensive genetic testing service for a cost of 4400 AED. This test is essential for individuals with a family history of SPG8 or those exhibiting symptoms, as it can offer critical insights into their condition and guide healthcare professionals in developing an effective treatment plan.
The MYOT Gene Spheroid Body Myopathy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the MYOT gene, which are associated with the development of Spheroid Body Myopathy (SBM). SBM is a rare, inherited muscle disorder characterized by muscle weakness and the presence of spheroid bodies within muscle fibers, visible under a microscope. The condition is progressive and can lead to significant impairment over time.
This genetic test is crucial for individuals with a clinical presentation suggestive of SBM or those with a family history of the disease, as early and accurate diagnosis is key to managing symptoms and planning for potential treatments. The test involves analyzing the patient's DNA, extracted from a blood sample, to identify any mutations in the MYOT gene that are linked to the condition.
At DNA Labs UAE, the cost of the MYOT Gene Spheroid Body Myopathy Genetic Test is 4400 AED. This cost includes the full process of sample collection, DNA analysis, and a comprehensive report detailing the findings. The results from this test can provide invaluable information for affected individuals and their families, guiding clinical decisions and genetic counseling. It is a critical step towards personalized medicine for patients with this rare genetic disorder.
The AR Gene Spinal and Bulbar Muscular Atrophy X-Linked Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the AR gene, which are responsible for Spinal and Bulbar Muscular Atrophy (SBMA), also known as Kennedy's disease. This condition is an X-linked recessive disorder, meaning it predominantly affects males, though females can be carriers. SBMA is characterized by the degeneration of motor neurons in the spinal cord and brainstem, leading to muscle weakness and atrophy, as well as bulbar involvement that affects speech and swallowing.
The test involves analyzing the patient's DNA to identify specific mutations in the androgen receptor (AR) gene, which plays a crucial role in the development and maintenance of male characteristics. Mutations in this gene lead to the abnormal expansion of a CAG trinucleotide repeat, causing the neurological and muscular symptoms associated with SBMA.
Offered at a cost of 4400 AED, this genetic test is a critical tool for confirming the diagnosis of SBMA, enabling early intervention and management of the condition. It also provides essential information for family planning, as it can help identify carriers of the mutation who may be at risk of passing the condition to their offspring. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test is a cornerstone in the personalized approach to genetic disorders, offering hope and support to affected individuals and their families.
The SMN1 Gene Spinal Muscular Atrophy Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA) Type 1. SMA Type 1, also known as Werdnig-Hoffmann disease, is a severe form of spinal muscular atrophy that manifests in infancy and is characterized by muscle weakness and atrophy resulting from the degeneration of motor neurons in the spinal cord. The test is crucial for early diagnosis and management of the condition, allowing for timely intervention and support for affected individuals and their families. Priced at 4400 AED, this genetic test provides a valuable tool for clinicians and genetic counselors in the assessment and understanding of this genetic disorder, paving the way for personalized treatment plans and improved patient outcomes.
The SMN1 Gene Spinal Muscular Atrophy Type 2 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA) Type 2. SMA Type 2 is a genetic disorder characterized by progressive muscle weakness and atrophy, typically manifesting in early childhood. This condition is caused by the loss or mutation of the survival motor neuron 1 (SMN1) gene, which is crucial for the maintenance and function of motor neurons.
The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and then analyzing the genetic material for specific mutations in the SMN1 gene. This precise genetic testing allows for an accurate diagnosis of SMA Type 2, enabling healthcare providers to tailor treatment plans and interventions to the specific needs of the patient. Early diagnosis through genetic testing is vital for managing symptoms, improving quality of life, and understanding the prognosis of the condition. DNA Labs UAE offers this test as part of its comprehensive suite of genetic diagnostic services, employing state-of-the-art technology and methodologies to ensure accurate and reliable results.
The SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA) Type 3. SMA Type 3, also known as Kugelberg-Welander disease, is a genetic disorder characterized by progressive muscle weakness and atrophy, primarily affecting the proximal muscles. This condition is caused by a reduction in the survival motor neuron protein due to mutations in the SMN1 gene.
This genetic test is crucial for early diagnosis, allowing for timely intervention and management of the condition. It involves analyzing the patient's DNA to detect the presence of specific mutations in the SMN1 gene that are responsible for SMA Type 3. Early diagnosis through this test can significantly impact the patient's quality of life, enabling access to supportive therapies and potential treatments that can slow the progression of the disease.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test is 4400 AED. DNA Labs UAE employs cutting-edge technology and highly qualified professionals to ensure accurate and reliable test results, providing crucial information for patients and their families to manage SMA Type 3 effectively.
The DNAJB2 gene is closely associated with a form of spinal muscular atrophy (SMA) known as type 5. SMA type 5 is a rare genetic disorder characterized by progressive muscle weakness and atrophy, primarily affecting the motor neurons in the spinal cord. The DNAJB2 gene plays a crucial role in the maintenance and function of these neurons. Mutations in this gene can lead to the development of SMA type 5, making genetic testing for these mutations an important tool for diagnosis and family planning.
DNA Labs UAE offers a specialized genetic test for the DNAJB2 gene to help identify mutations that are associated with spinal muscular atrophy type 5. This test is crucial for individuals with a family history of SMA or those exhibiting symptoms related to motor neuron dysfunction. By analyzing the DNAJB2 gene, the test can confirm a diagnosis, allowing for early intervention and management strategies to be implemented. Additionally, it can provide essential information for families considering future pregnancies.
The cost of the DNAJB2 gene spinal muscular atrophy type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect mutations in the DNAJB2 gene accurately. Given the complexity of genetic testing and the specific expertise required to interpret the results, the cost reflects both the technological and professional resources involved in providing accurate and actionable information for patients and their families.
